[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].

Author: BoerK, DielemanJ P, GodfriedM H, TempelmanC, TimmermansS, van der EndeM E

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To assess the side effects, safety and efficacy of highly active antiretroviral therapy (HAART) in a cohort of HIV-infected pregnant women in the Netherlands. DESIGN: Retrospective. METHOD: Data were collected from the medical records of HIV-infected pregnant women who received HAART du...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15553999

データ提供:米国国立医学図書館(NLM)

HAART: A Beacon of Hope for HIV-Positive Pregnant Women

The [management of HIV in pregnancy] is a complex and crucial aspect of [maternal and child health]. This study investigates the safety, efficacy, and side effects of highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands. It's like navigating a complex desert landscape, seeking ways to ensure the health of both mother and child. The researchers reviewed medical records of HIV-positive pregnant women who received HAART during pregnancy, examining the impact of this treatment on maternal and fetal health.

HAART: A Promising Treatment Option for HIV-Positive Mothers

The study found that HAART regimens containing nelfinavir or nevirapine were safe, effective, and well-tolerated in HIV-positive pregnant women. This is a significant discovery, like finding a safe haven in a treacherous desert. The findings suggest that HAART can be a valuable tool for managing HIV in pregnancy, minimizing the risk of transmission to the infant and improving maternal health.

Protecting Mothers and Children: A Shared Journey

This study highlights the importance of providing safe and effective treatment options for HIV-positive pregnant women. It's a reminder that the journey to a healthy future requires a shared effort, like a caravan navigating the desert together. The findings underscore the ongoing efforts to develop and refine treatments that protect both mothers and children from the devastating effects of HIV.

Dr. Camel's Conclusion

This study offers a ray of hope for HIV-positive pregnant women, demonstrating the efficacy and safety of HAART in this population. It highlights the importance of continued research and development in the field of HIV treatment, paving the way for a future where HIV-positive mothers and their children can thrive.

Date :
  1. Date Completed 2004-12-16
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

15553999

DOI: Digital Object Identifier

15553999

Related Literature

SNS
PICO Info
in preparation
Languages

Dutch

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.